Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?

Abel, Mary Kathryn; Melisko, Michelle E; Rugo, Hope S; Chien, A Jo; Diaz, Italia; Levine, Julia K; Griffin, Ann; McGuire, Joseph; Esserman, Laura J; Borno, Hala T; Mukhtar, Rita A

Abel, Mary Kathryn; Melisko, Michelle E; Rugo, Hope S; Chien, A Jo; Diaz, Italia; Levine, Julia K; Griffin, Ann; McGuire, Joseph; Esserman, Laura J; Borno, Hala T; Mukhtar, Rita A.

Afiliación

Abel MK; University of California, San Francisco School of Medicine, San Francisco, CA, USA.
Melisko ME; University of California, San Francisco, Department of Surgery, San Francisco, CA, USA.
Rugo HS; University of California at San Francisco, Division of Hematology/Oncology, San Francisco, CA, USA.
Chien AJ; University of California at San Francisco, Division of Hematology/Oncology, San Francisco, CA, USA.
Diaz I; University of California at San Francisco, Division of Hematology/Oncology, San Francisco, CA, USA.
Levine JK; University of California, Davis School of Medicine, Sacramento, CA, USA.
Griffin A; Lobular Breast Cancer Alliance, Venice, CA, USA.
McGuire J; Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
Esserman LJ; Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
Borno HT; University of California, San Francisco, Department of Surgery, San Francisco, CA, USA.
Mukhtar RA; University of California at San Francisco, Division of Hematology/Oncology, San Francisco, CA, USA.

NPJ Breast Cancer ; 7(1): 139, 2021 Oct 25.

Article en En | MEDLINE | ID: mdl-34697300

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Breast Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google